Segregation analysis of two-locus models regulating apolipoprotein-A1 levels

Genetic Epidemiology

Volumn 15, Issue 1, 1998, Pages 73-86

  Juo, S H ^a   Beaty, T H ^a   Xu, J ^b   Prenger, V L ^b   Coresh, J ^a,c   Kwiterovich Jr , P O ^c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apolipoprotein A1; Coronary artery disease; Genetics; One locus segregation analysis; Two locus segregation analysis

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FAMILY STUDY; FEMALE; GENE LOCUS; GENETIC LINKAGE; HUMAN; MAJOR CLINICAL STUDY; MALE; SEGREGATION ANALYSIS; STATISTICAL ANALYSIS;

APOLIPOPROTEIN A-I; CHROMOSOME MAPPING; CORONARY ANGIOGRAPHY; CORONARY DISEASE; FEMALE; GENETICS, POPULATION; GENOTYPE; HUMANS; LINEAR MODELS; MALE; MEIOSIS; MIDDLE AGED; MODELS, GENETIC;

EID: 0031907497     PISSN: 07410395     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2272(1998)15:1<73::AID-GEPI6>3.0.CO;2-5     Document Type: Article

References (32)

1. Akaike H (1974): A new look at the statistical model identification. IEEE Trans Automatic Control AC 19:719-723.
2. Amos CI, Elston RC, Srinivasan SR, Wilson AF, Cresama JL, Ward LJ, Berenson GS (1987): Linkage and segregation analysis of apolipoproteins-A1 and B, and lipoprotein cholesterol levels in a large pedigree with excess coronary heart disease: The Bogalusa Heart Study. Genet Epidemiol 4: 115-128.
3. Barbir M, Wile D, Trayner I, Aber VR, Thompson GR (1988): High prevalence of hypertriglyceridaemia and apolipoprotein abnormalities in coronary artery disease. Br Heart J 60:397-403.
4. Berg K (1982): The genetics of the hyperlipidemias and coronary artery disease. Prog Clin Biol Res 103:111-125.
5. Blanger J, MacCluer JW, Kammerer CM, Mott GE, Dyer TD, McGill HC Jr (1990): Genetic analysis of apolipoprotein A-1 in two dietary environments. Am J Hum Genet 47:414-428.
6. Blangero J, Williams-Blangero S, Mahaney MC (1993): Multivariate genetic analysis of apo-A1 concentrations and HDL subfractions: Evidence for major locus pleiotrophy. Genet Epidemiol 10:617-622.
7. Borecki BI, Laskarzewski P, Rao DC (1988): Genetic factors influencing apolipoprotein. AI and AII levels in a kindred with premature coronary heart disease. Genet Epidemiol 5:393-406.
8. Brinton EA, Eisenberg S, Breslow JL (1994): Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution. Arterioscler Thromb 14:707-720.
9. Bu X, Warden CH, Xia YR, De Meester C, Puppione DL, Teruya S, Lokensgard B, Daneshmand S, Brown J, Gray RJ, Rotter JI, Lusis AJ (1994): Linkage analysis of the genetic determinants of high density lipoprotein concentrations and composition: Evidence for involvement of the apolipoprotein A-II and cholesteryl ester transfer protein loci. Hum Genet 93:639-648.
10. Buring JE, O'Connor GT, Goldhaber SZ, Rosner B, Herbert PN, Blum CB, Breslow JL, Hennekens CH (1992): Decreased HDL2 and HDL3 cholesterol, Apo A-I and Apo A-II, and increased risk of myocardial infarction. Circulation 85:22-29.
11. Fielding CJ, Shore VG, Fielding PE (1972): A protein cofactor of lecithin:cholesterol acyltransferase. Biochem Biophys Res Commun 467:1493-1498.
12. Goldberg IJ, Blaner WS, Vanni TM, Moukides M, Ramakrishnan R (1990): Role of lipoprotein lipase in the regulation of high density lipoprotein apolipoprotein metabolism. Studies in normal and lipoprotein lipase-inhibited monkeys. J Clin Invest 86:463-473.
13. Haffner SM, Kushwaha RS, Foster DM, Applebaum-Bowden D, Hazzard WR (1983): Studies on the metabolic mechanism of reduced high density lipoproteins during anabolic steroid therapy. Metabolism 32:413-420.
14. Hamsten A, Iselius L, Dahlen G, De Faire U (1986): Genetic and cultural inheritance of serum lipid, low and high density lipoprotein cholesterol and serum apolipoprotein A-I, A-II and B. Atherosclerosis 60:199-208.
15. Hasstedt SJ (1994): Pedigree analysis package (PAP) Revision 4.0. University of Utah, Salt Lake City.
16. Hasstedt SJ, Alberts JJ, Cheung MC, Jorde LB, Wilson DE, Edwards CQ, Cannon WN, Ash KO, Williams RR (1984): The inheritance of high density lipoprotein cholesterol and apolipoprotein A-I and A-II. Atherosclerosis 51:21-29.
17. Jeenah M, Kessling A, Miller N, Humphries S (1990): G to A substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI and HDL-C. Mol Biol Med 7:233-241.
18. Kammerer CM, Hixson JE, Blangero J, MacCluer JW (1988): Relationship between RFLP's for apo AI and LCAT and probable major gene genotypes for high density lipoprotein cholesterol and apo AI serum concentration in Baboons. Am J Hum Genet 43(Suppl):A216.
19. Kuusi T, Kesaniemi YA, Vuoristo M, Miettinen TA, Koskenvuo M (1987): Inheritance of high density lipoprotein and lipoprotein lipase and hepatic lipase activity. Arteriosclerosis 7:421-425.
20. Kwiterovich PO Jr, Coresh J, Smith HH, Bachorik PS, Derby CA, Pearson TA (1992): Comparison of the plasma levels of apolipoproteins B and A-1, and other risk factors in men and women with premature coronary artery disease. Am J Cardiol 69:1015-1021.
21. Moll PP, Sing CF, Williams RR, Mao SJ, Kottke B (1986): The genetic determination of plasma apolipoprotein-A1 levels measured by radioimmunoassay: A study of high-risk pedigrees. Am J Hum Genet 38:361-372.
22. Moll P, Michels VV, Weidman WH, Kottke BA (1989): Genetic determination of plasma apolipoprotein-A1 in a population-based sample. Am J Hum Genet 44:124-139.
23. Oram JF, Brinton E, Bierman EL (1983): Regulation of high density lipoprotein receptor activity in cultured human skin fibroblasts and human arterial smooth muscle cells. J Clin Invest 72:1611-1622.
24. Prenger VL, Beaty TH, Kwiterovich PO (1992): Genetic determination of HDL-C and apo-A1 plasma levels in a family study of cardiac catheterization patients. Am J Hum Genet 51:1047-1057.
25. Saha N, Tay JS, Low PS, Humphries SE (1994): Guanidine to adenine (G/A) substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI levels in Chinese non-smokers. Genet Epidemiol 11:255-264.
26. Schork NJ, Boehnke M, Terwilliger JD, Ott J (1993): Two-trait-locus linkage analysis: A powerful strategy for mapping complex genetic traits. Am J Hum Genet 53:1127-1136.
27. Sigurdsson G, Bladursdottir A, Sigvaldason H, Agnarsson U, Thorgeirsson G, Sigfussion N (1992): Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men. Am J Cardiol 69:1251-1254.
28. Sistonen P, Ehnholm C (1980): On the heritability of serum high density lipoprotein in twins. Am J Hum Genet 32:1-7.
29. Suzuki N, Fidge N, Nestel P, Yin J (1983): Interaction of serum lipoproteins with the intestine: Evidence for specific high density lipoprotein binding sites on isolated rat intestinal mucosal cells. J Lipid Res 24:253-256.
30. Wald NJ, Law M, Watt HC, Wu T, Bailey A, Johnson AM, Craig WY, Ledue TB, Haddow JE (1994): Apolipoproteins and ischaemic heart disease: Implications for screening. Lancet 343:75-79.
31. Xu JF, Prenger VL, Coresh J, Beaty TH (1993): Two-locus and bivariate segregation analysis of HDL-C and apo-A1. Genet Epidemiol 10:605-610.
32. Xu JF, Levitt RC, Panhuysen CIM, Postma DS, Taylor EW, Amelung PJ, Holroyd KJ, Bleecker ER, Meyers DA (1995): Evidence of two unlinked loci regulating total serum IgE levels. Am J Hum Genet 57:425-430.